IFRX logo

InflaRx N.V.

IFRX
Healthcare|Biotechnology|DE
$1.30
-0.05 (-3.69%)
DCF Value
$0.19
Tangible Book / Share
$0.98
Cash / Share
$0.78
Next Earnings Report
Mar 18, 2027
EPS est. -$0.05 · Revenue est. $5.8K
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Aug 14, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

InflaRx Announces Publication of Phase 1 Data Demonstrating Favorable Safety and Pharmacokinetic/Pharmacodynamic Profile of Izicopan
Nov 6, 2026 · GlobeNewsWire
InflaRx Highlights Izicopan Development Path and Commercial Opportunity in ANCA-Associated Vasculitis at Capital Markets Day
Nov 3, 2026 · GlobeNewsWire
InflaRx Announces November Investor Events
Oct 27, 2026 · GlobeNewsWire
InflaRx Highlights Izicopan's Therapeutic Potential at Kidney Week 2026
Oct 22, 2026 · GlobeNewsWire
InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026
Oct 2, 2026 · GlobeNewsWire
InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development
Oct 1, 2026 · GlobeNewsWire
InflaRx to Host Virtual Capital Markets Day
Sep 21, 2026 · GlobeNewsWire
InflaRx Announces Participation in September Investor Conferences
Aug 20, 2026 · GlobeNewsWire

SEC Filings (51)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 6, 20266-KForeign issuer reportDocumentIndex
Nov 3, 20266-KForeign issuer reportDocumentIndex
Nov 3, 20266-KForeign issuer reportDocumentIndex
Oct 22, 20266-KForeign issuer reportDocumentIndex
Aug 17, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2026424B5Offering prospectusDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 12, 2026EFFECTDocumentIndex
Aug 6, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 6, 2026F-3Shelf registrationDocumentIndex
Aug 6, 2026S-8Employee stock planDocumentIndex
Aug 6, 20266-KForeign issuer reportDocumentIndex
Jun 30, 20266-KForeign issuer reportDocumentIndex
May 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 12, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 7, 20266-KForeign issuer reportDocumentIndex
May 7, 2026424B5Offering prospectusDocumentIndex
May 6, 2026424B5Offering prospectusDocumentIndex
May 6, 20266-KForeign issuer reportDocumentIndex
May 6, 20266-KForeign issuer reportDocumentIndex
May 4, 20266-KForeign issuer reportDocumentIndex
Apr 28, 20266-KForeign issuer reportDocumentIndex
Apr 23, 20266-KForeign issuer reportDocumentIndex
Apr 9, 20266-KForeign issuer reportDocumentIndex
Apr 2, 20266-KForeign issuer reportDocumentIndex
Mar 20, 202620-FAnnual report (foreign)DocumentIndex
Mar 19, 20266-KForeign issuer reportDocumentIndex
Mar 16, 20266-KForeign issuer reportDocumentIndex
Feb 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 8, 20266-KForeign issuer reportDocumentIndex
Dec 30, 20256-KForeign issuer reportDocumentIndex
Nov 10, 20256-KForeign issuer reportDocumentIndex
Nov 10, 20256-KForeign issuer reportDocumentIndex
Sep 12, 20256-KForeign issuer reportDocumentIndex
Aug 7, 20256-KForeign issuer reportDocumentIndex
Jul 14, 20256-KForeign issuer reportDocumentIndex
Jun 27, 20256-KForeign issuer reportDocumentIndex
May 28, 20256-KForeign issuer reportDocumentIndex